TherapeuticsMD Company Profile (NYSEMKT:TXMD)

About TherapeuticsMD

TherapeuticsMD logoTherapeuticsMD, Inc. is a women's healthcare product company. The Company's segment is creating and commercializing products for women. It is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. Its drug candidates are created using its SYMBODA hormone technology, which enables the administration of hormones with high bioavailability alone or in combination. The Company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. The Company's product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD RediChew Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, itaMedMD Menopause Relief with Lifenol Plus Bone Support, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: TXMD
  • CUSIP:
Key Metrics:
  • Previous Close: $6.88
  • 50 Day Moving Average: $7.53
  • 200 Day Moving Average: $7.60
  • 52-Week Range: $5.18 - $11.26
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -22.19
  • P/E Growth: 0.00
  • Market Cap: $1.35B
  • Outstanding Shares: 196,492,000
  • Beta: 1.28
Additional Links:
Companies Related to TherapeuticsMD:

Analyst Ratings

Consensus Ratings for TherapeuticsMD (NYSEMKT:TXMD) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.50

Analysts' Ratings History for TherapeuticsMD (NYSEMKT:TXMD)
Show:
DateFirmActionRatingPrice TargetDetails
4/6/2016Jefferies GroupReiterated RatingBuy$18.00View Rating Details
4/4/2016Goldman Sachs Group Inc.Initiated CoverageBuy$10.00View Rating Details
2/28/2016Noble FinancialReiterated RatingBuy$18.00 -> $17.50View Rating Details
12/8/2015GuggenheimBoost Price TargetBuy$33.00View Rating Details
12/8/2015Stifel NicolausBoost Price TargetBuy$10.00 -> $14.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for TherapeuticsMD (NYSEMKT:TXMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2016Q116($0.09)($0.11)$5.73 million$4.93 millionViewN/AView Earnings Details
2/25/2016Q415($0.10)($0.10)$5.33 million$5.63 millionViewListenView Earnings Details
11/4/2015Q315($0.12)($0.11)$5.01 million$5.19 millionViewN/AView Earnings Details
8/6/2015Q215($0.11)($0.16)$4.65 million$4.80 millionViewListenView Earnings Details
5/5/2015($0.10)($0.13)ViewN/AView Earnings Details
3/10/2015Q414($0.09)($0.10)$2.86 million$4.26 millionViewN/AView Earnings Details
11/6/2014Q3 14($0.08)($0.12)ViewN/AView Earnings Details
5/6/2014Q1 14($0.06)($0.06)$3.08 million$2.80 millionViewN/AView Earnings Details
3/3/2014Q213($0.06)($0.06)$2.72 million$2.90 millionViewN/AView Earnings Details
5/8/2013Q113($0.06)($0.06)$1.32 million$1.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for TherapeuticsMD (NYSEMKT:TXMD)
Current Year EPS Consensus Estimate: $-0.43 EPS
Next Year EPS Consensus Estimate: $-0.31 EPS

Dividends

Dividend History for TherapeuticsMD (NYSEMKT:TXMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for TherapeuticsMD (NYSEMKT:TXMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/11/2016Cooper C CollinsDirectorBuy16,000$6.23$99,680.00View SEC Filing  
8/25/2015Angus C RussellDirectorBuy13,500$5.98$80,730.00View SEC Filing  
6/8/2015Mitchell KrassanEVPSell30,000$8.18$245,400.00View SEC Filing  
5/12/2015Angus C RussellDirectorBuy35,000$6.15$215,250.00View SEC Filing  
5/11/2015Tommy G ThompsonChairmanBuy6,000$6.09$36,540.00View SEC Filing  
5/8/2015J Martin CarrollDirectorBuy10,000$6.11$61,100.00View SEC Filing  
11/21/2014Daniel A CartwrightCFOSell40,000$3.91$156,400.00View SEC Filing  
9/4/2014Tommy G ThompsonDirectorBuy1,757$5.44$9,558.08View SEC Filing  
6/5/2014Cooper C CollinsDirectorBuy20,000$3.84$76,800.00View SEC Filing  
5/9/2014Robert Lapenta, Jr.DirectorBuy5,000$3.66$18,300.00View SEC Filing  
5/8/2014Tommy ThompsonDirectorBuy14,000$3.57$49,980.00View SEC Filing  
3/26/2014Brian BernickDirectorSell421,268$6.70$2,822,495.60View SEC Filing  
3/26/2014John C.K. Iv MilliganInsiderSell353,412$6.70$2,367,860.40View SEC Filing  
3/26/2014Robert FinizioCEOSell982,053$6.70$6,579,755.10View SEC Filing  
3/10/2014Mitchell KrassanEVPSell7,500$7.73$57,975.00View SEC Filing  
2/26/2014John C.K. Iv MilliganPresidentSell25,000$6.31$157,750.00View SEC Filing  
2/21/2014Robert FinizioCEOSell50,000$6.17$308,500.00View SEC Filing  
2/12/2014Brian BernickDirectorSell31,250$6.16$192,500.00View SEC Filing  
1/30/2014John C.K. Iv MilliganInsiderSell25,000$6.16$154,000.00View SEC Filing  
1/23/2014Robert G FinizioCEOSell50,000$5.70$285,000.00View SEC Filing  
1/13/2014Mitchell KrassanEVPSell7,500$5.73$42,975.00View SEC Filing  
1/8/2014Brian BernickDirectorSell31,250$5.13$160,312.50View SEC Filing  
8/26/2013Brian BernickInsiderSell1,600,000$1.55$2,480,000.00View SEC Filing  
8/26/2013Jules A MusingDirectorBuy5,282$2.15$11,356.30View SEC Filing  
6/14/2013Cooper C CollinsDirectorSell2,631,579$1.75$4,605,263.25View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for TherapeuticsMD (NYSEMKT:TXMD)
DateHeadline
News IconThe Key Numbers To Watch From TherapeuticsMD, Inc. (NYSEMKT:TXMD)'s Earnings - The Voice Registrar (NYSEMKT:TXMD)
voiceregistrar.com - August 30 at 7:43 PM
News IconHC Stocks Overview: HCA Holdings Inc (HCA), TherapeuticsMD Inc (NYSEMKT:TXMD) - share market updates (press release) (NYSEMKT:TXMD)
sharemarketupdates.com - August 30 at 11:17 AM
News IconHealthcare Stocks in the Spotlight: TherapeuticsMD Inc (NYSEMKT ... - Post Registrar (NYSEMKT:TXMD)
postregistrar.com - August 23 at 12:30 PM
News IconStock Tracking Lower for the Quarter: TherapeuticsMD, Inc. (:TXMD) - Post News (NYSEMKT:TXMD)
www.kentuckypostnews.com - August 20 at 11:54 AM
nasdaq.com logoTherapeuticsMD Becomes Oversold (TXMD) - Nasdaq (NYSEMKT:TXMD)
www.nasdaq.com - August 20 at 11:54 AM
nasdaq.com logoTherapeuticsMD Becomes Oversold (TXMD) (NYSEMKT:TXMD)
www.nasdaq.com - August 19 at 7:50 PM
finance.yahoo.com logoEdited Transcript of TXMD earnings conference call or presentation 4-Aug-16 8:30pm GMT (NYSEMKT:TXMD)
finance.yahoo.com - August 17 at 10:56 AM
News IconTop Earnings to Watch for: TherapeuticsMD, Inc. (NYSEMKT:TXMD) - The Voice Registrar (NYSEMKT:TXMD)
voiceregistrar.com - August 16 at 8:03 PM
tradecalls.org logoTherapeuticsMD (TXMD) Shares are Down -0.13% - Trade Calls (NYSEMKT:TXMD)
www.tradecalls.org - August 8 at 8:29 AM
News IconNotable Watch List: Amber Road Inc (NYSE:AMBR), TherapeuticsMD Inc (NYSEMKT:TXMD) - NYSE Journal (press release) (NYSEMKT:TXMD)
stockznews.com - August 7 at 7:33 PM
News IconWatch List: Amber Road Inc (NYSE:AMBR), TherapeuticsMD Inc (NYSEMKT:TXMD) - NYSE Journal (press release) (NYSEMKT:TXMD)
stockznews.com - August 7 at 9:56 AM
tradecalls.org logoGilder Gagnon Howe Co Lowers stake in TherapeuticsMD Inc (TXMD) - Trade Calls (NYSEMKT:TXMD)
www.tradecalls.org - August 5 at 8:12 PM
fortune.com logoAnalyst Opinions To Note: TherapeuticsMD Inc (NYSEMKT:TXMD), PDL BioPharma Inc (NASDAQ:PDLI) - Review Fortune (NYSEMKT:TXMD)
reviewfortune.com - August 2 at 8:41 AM
ftsenews.co.uk logoTherapeuticsMD, Inc. (TXMD) Updated Price Targets - FTSE News (NYSEMKT:TXMD)
www.ftsenews.co.uk - July 27 at 11:06 AM
streetupdates.com logoAnalysts Ranking Activities: Celgene Corporation (NASDAQ:CELG) , TherapeuticsMD, Inc. (NYSEMKT:TXMD) - Street Updates (NYSEMKT:TXMD)
www.streetupdates.com - July 26 at 11:34 AM
tradecalls.org logoTherapeuticsMD (TXMD) Shares are Down -2.75% - Trade Calls (NYSEMKT:TXMD)
www.tradecalls.org - July 25 at 8:12 PM
equities.com logoTherapeuticsMD Inc. (TXMD) is Trading Higher on Unusual Volume for July 21 - Equities.com (NYSEMKT:TXMD)
www.equities.com - July 23 at 11:45 AM
istreetwire.com logoStocks Intraday Alert: TherapeuticsMD, Inc. (TXMD), CytRx Corporation (CYTR), Tractor Supply Company (TSCO) - iStreetWire (NYSEMKT:TXMD)
istreetwire.com - July 22 at 7:49 PM
streetupdates.com logoTargeted Movers: TherapeuticsMD, Inc. (NYSEMKT:TXMD) , Skyline Medical Inc. (NASDAQ:SKLN) - Street Updates (NYSEMKT:TXMD)
www.streetupdates.com - July 22 at 7:49 PM
News IconStock Alert: Unusual Volume Watch for TherapeuticsMD, Inc. (:TXMD) - Engelwood Daily (NYSEMKT:TXMD)
www.engelwooddaily.com - July 22 at 10:53 AM
News IconStock Moving Lower for the Month; Investor Update on TherapeuticsMD, Inc. (:TXMD) - Engelwood Daily (NYSEMKT:TXMD)
www.engelwooddaily.com - July 21 at 8:19 PM
news.cmlviz.com logoOption Market: TherapeuticsMD Inc (AMEX:TXMD) Risk Hits An Inflection Point - CML News (NYSEMKT:TXMD)
news.cmlviz.com - July 21 at 8:19 PM
news.cmlviz.com logoTherapeuticsMD, Inc. (AMEX:TXMD) Fundamental Star Rating Report - CML News (NYSEMKT:TXMD)
news.cmlviz.com - July 20 at 10:51 AM
streetupdates.com logoKeep an eye on Analyst Actions: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , TherapeuticsMD, Inc. (NYSEMKT ... - Street Updates (NYSEMKT:TXMD)
www.streetupdates.com - July 19 at 9:43 AM
News IconSolid Performer in Focus: TherapeuticsMD, Inc. (:TXMD) - Engelwood Daily (NYSEMKT:TXMD)
www.engelwooddaily.com - July 19 at 9:43 AM
News IconTherapeuticsmd (NYSEMKT:TXMD) Short Interest Increased By 2.2% - Consumer Eagle (NYSEMKT:TXMD)
www.consumereagle.com - July 18 at 3:34 PM
News IconShares Moving Down on the Week: TherapeuticsMD, Inc. (:TXMD) - Engelwood Daily (NYSEMKT:TXMD)
www.engelwooddaily.com - July 17 at 8:46 AM
News IconShares Experiencing a Downtrend: TherapeuticsMD, Inc. (:TXMD) - TGP (NYSEMKT:TXMD)
telanaganapress.com - July 16 at 11:08 AM
equities.com logoTherapeuticsMD Inc. (TXMD) is Trading Higher on Unusual Volume for July 14 - Equities.com (NYSEMKT:TXMD)
www.equities.com - July 16 at 11:08 AM
News IconStock Tracking Higher in Session: TherapeuticsMD, Inc. (:TXMD) - Telanagana Press (NYSEMKT:TXMD)
telanaganapress.com - July 14 at 8:13 PM
equities.com logoTherapeuticsMD Inc. (TXMD) Drops 6.17% on July 13 - Equities.com (NYSEMKT:TXMD)
www.equities.com - July 14 at 8:13 PM
streetupdates.com logoSummary of Analyst's Study: Galena Biopharma, Inc. (NASDAQ:GALE) , TherapeuticsMD, Inc. (NYSEMKT:TXMD) - Street Updates (NYSEMKT:TXMD)
www.streetupdates.com - July 12 at 12:17 PM
News IconMakes Perfect Disruptive Tech Pair- TherapeuticsMD (NYSEMKT:TXMD), Novartis (NYSE:NVS), Coeur Mining (NYSE ... - Seneca Globe (NYSEMKT:TXMD)
www.senecaglobe.com - July 12 at 12:17 PM
News IconHealthcare Unusual Volume Gianers- Humana (NYSE:HUM), TherapeuticsMD (NYSEMKT:TXMD) - Seneca Globe (NYSEMKT:TXMD)
www.senecaglobe.com - July 12 at 12:17 PM
News IconShares Moving Up Over the Past Quarter: TherapeuticsMD, Inc. (:TXMD) - Engelwood Daily (NYSEMKT:TXMD)
www.engelwooddaily.com - July 12 at 12:17 PM
news.cmlviz.com logoTherapeuticsMD Inc Realized Volatility Hits Substantially Low Level - CML News (NYSEMKT:TXMD)
news.cmlviz.com - July 12 at 12:17 PM
insidermonkey.com logoNDA Watch: TherapeuticsMD Inc (TXMD) and Yuvvexy - Insider Monkey (blog) (NYSEMKT:TXMD)
www.insidermonkey.com - July 12 at 12:17 PM
News IconNDA Watch: TherapeuticsMD Inc (TXMD) and Yuvvexy (NYSEMKT:TXMD)
feedproxy.google.com - July 11 at 2:39 PM
tradecalls.org logoCompany Shares of TherapeuticsMD (NYSEMKT:TXMD) Drops by -5.52% - Trade Calls (NYSEMKT:TXMD)
www.tradecalls.org - July 11 at 8:25 AM
News IconStock Performance Rundown on: TherapeuticsMD, Inc. (:TXMD) - Press Telegraph (NYSEMKT:TXMD)
presstelegraph.com - July 11 at 8:25 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For TherapeuticsMD, Inc. (TXMD) - Fiscal Standard (NYSEMKT:TXMD)
www.fiscalstandard.com - July 10 at 7:05 PM
News IconShares Finishing Down for the Week TherapeuticsMD, Inc. (:TXMD) - Engelwood Daily (NYSEMKT:TXMD)
www.engelwooddaily.com - July 8 at 7:53 PM
News IconUnusual Volume on Shares of: TherapeuticsMD, Inc. (:TXMD) - Engelwood Daily (NYSEMKT:TXMD)
www.engelwooddaily.com - July 8 at 7:53 PM
capitalcube.com logoTherapeuticsMD, Inc. breached its 50 day moving average in a Bearish Manner : TXMD-US : July 8, 2016 (NYSEMKT:TXMD)
www.capitalcube.com - July 8 at 8:25 AM
streetinsider.com logoTherapeuticsMD (TXMD) Submits NDA for Yuvvexy with U.S. FDA - StreetInsider.com (NYSEMKT:TXMD)
www.streetinsider.com - July 7 at 8:02 PM
businesswire.com logoTherapeuticsMD Announces New Drug Application Submission for Yuvvexy™ (TX-004HR) (NYSEMKT:TXMD)
www.businesswire.com - July 7 at 8:02 PM
News IconStock Tracking Down This Month; Investor Alert on TherapeuticsMD, Inc. (:TXMD) - Engelwood Daily (NYSEMKT:TXMD)
www.engelwooddaily.com - July 6 at 8:16 AM
News IconShare Performance Recap for: TherapeuticsMD, Inc. (:TXMD) - Press Telegraph (NYSEMKT:TXMD)
presstelegraph.com - July 3 at 7:08 PM
capitalcube.com logoETF’s with exposure to TherapeuticsMD, Inc. : June 30, 2016 (NYSEMKT:TXMD)
www.capitalcube.com - June 30 at 12:42 PM
bizjournals.com logoMomentum Indicators for Drug Manufacturers - Major Equities -- Sanofi, TherapeuticsMD, Immune Pharma, and Heron Therapeutics (NYSEMKT:TXMD)
www.bizjournals.com - June 30 at 10:41 AM

Social


Last Updated on 8/30/2016 by MarketBeat.com Staff